Advertisement
Advertisement
ONC
BeOne Medicines Ltd. - ADR
327.53
USDSponsored
+4.52
+1.40%
Aug 05, 15:59 UTC -4
Closed
Pre-Market
326.73
-0.80
-0.24%
BeOne Medicines Ltd. - ADR Profile
About
Info & Links
CEO
John V. Oyler
Headquarters
BASEL, V8 4051, SWITZERLAND
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
31,846
Employees
12,000
BeOne Medicines Ltd. - ADR Statistics
Valuation Measures
Market Capitalization2
33.90B
Enterprise Value
30.19B
Enterprise Value/EBITDA(ttm)
36.11
Price to Earnings Ratio(ttm)
72.26
Price to Sales(ttm)
6.18
Price to Book(mrq)
7.44
Price to Cash(ytd)
82.64
Profitability
Gross Margin(ttm)
88.25%
Operating Margin(ttm)
8.94%
Profit Margin(ttm)
8.87%
Return on Equity(ttm)
12.06%
Return on Invested Capital(ttm)
10.55%
Return on Assets(ttm)
6.69%
Income Statement
Revenue(ttm)
5.74B
Revenue Per Share(ttm)
51.62
Gross Profit(ttm)
5.07B
EBITDA(ttm)3
835.96M
Net Income Available to Common(ttm)
513.02M
Diluted EPS(ttm)
4.47
Share Statistics
Beta (5Y Monthly)
0.49
52-Week Change
6.61%
S&P 500 52-Week Change
21.73%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
111.17M
Dividend Yield
0.00%
Float4
102.93M
% Held by Insiders
6.19%
% Held by Institutions
48.55%
Balance Sheet
Total Cash(mrq)
4.79B
Total Cash Per Share(mrq)
43.10
Total Debt(mrq)
1.08B
Total Debt/Equity(mrq)
22.66%
Current Ratio(mrq)
3.64%
Quick Ratio(mrq)
3.27%
Book Value Per Share(mrq)
42.84
Cash Flow
Operating Cash Flow Per Share(ytd)
1.74
Free Cash Flow(ytd)
160.55M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement